Weekly Roundup: September 18-24, 2026


More from:

This roundup contains a collection of the posts published on the Forum during the week of September 18-24, 2026

Remarks by Chairman Atkins on 24-Hour Trading


Statement by Commissioner Peirce on the Innovation Exemption


Forced CEO Departures


The Risks of Designated Directorships—Current Guidance for Directors and Those Who Appoint Them


A Breakout Year for CVRs: 2025 and First-Half 2026 Trends in Life Sciences Public M&A



FDA and SEC Open a New Information-Sharing Channel: Implications for Public Life Sciences Companies


Compensation Clawbacks – Surveying the Disclosures to Date


SEC Proposes to Rescind Rule 14a-8


The CEO Decision: How PE Investors Select and Reassess Leaders from Entry to Exit


Dodiya v. Franklin and the Emerging Rules of the DGCL’s Section 144 Safe Harbors


Rescission of Rule 14a-8: Anticipating the Potential Evolution of Shareholder Engagement Strategies



More from: